Learn how to inject Tresiba® (insulin degludec) using the FlexTouch® pen or the Tresiba® vial. Find information about injecting insulin. Read important safety and prescribing info on this page.

Tresiba ® FlexTouch ® is a prefilled insulin pen from Novo Nordisk Compatible with most universal fit needles. We recommended NovoFine ® Plus 32G Tip, one of the shortest, thinnest needles available.

Tresiba ® (insulin degludec) injection is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Tresiba ® is not recommended for treating diabetic ketoacidosis. Never Share a Tresiba® FlexTouch® Pen, Needle, or Syringe Between Patients, even if the needle is changed.

What needle do you use with your pen device? NovoFine ® Plus 32G 4mm needles are included in sample packs and prescription trade packs of certain GLP-1 RAs with compatible pen devices. NovoFine ® Plus 32G 4mm needles are currently not available in 100‑count boxes. Designed to improve skin contact and comfort.

Easy-to-read patient leaflet for Insulin Degludec (U-100) Prefilled Pens. Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content

is taken by subcutaneous injection once daily. Your health care provider will tell you how to take Tresiba based on your individual needs. If you think you need to adjust your insulin dose because of illness, new medicine, stress, change in diet, or change in activity level, make sure to talk to your health care provider.

TRESIBA® (insulin degludec) injection, for subcutaneous use Initial U.S. Approval: 2015. TRESIBA® is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus (1). Not recommended for …

Insulin Degludec is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus (1). Not recommended for the treatment of diabetic ketoacidosis. See Full Prescribing Information for …

Do not share your insulin product with another person. This includes any pens, cartridge devices, needles, or syringes, even if the needle has been changed. Sharing may pass infections from one person to another.

Jan 10, 2024 · Insulin degludec is administered as a subcutaneous injection into the skin with a needle and syringe or a prefilled pen. Insulin degludec takes effect in 30 to 90 minutes, and is slowly released, with peak effects at 9 hours and effects lasting for 24 hours.